Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Protagonist Therapeutics Debt to Equity Ratio 2015-2019 | PTGX

Current and historical debt to equity ratio values for Protagonist Therapeutics (PTGX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Protagonist Therapeutics debt/equity for the three months ending March 31, 2019 was 0.07.
Protagonist Therapeutics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-03-31 $0.01B $0.10B 0.07
2018-12-31 $0.00B $0.11B 0.00
2018-09-30 $0.00B $0.12B 0.00
2018-06-30 $0.00B $0.11B 0.00
2018-03-31 $0.00B $0.12B 0.00
2017-12-31 $0.00B $0.12B 0.00
2017-09-30 $0.00B $0.06B 0.00
2017-06-30 $0.00B $0.06B 0.00
2017-03-31 $0.00B $0.08B 0.00
2016-12-31 $0.00B $0.09B 0.00
2016-09-30 $0.00B $0.10B 0.00
2016-06-30 $0.00B $-0.05B 0.00
2016-03-31 $0.00B 0.00
2015-12-31 $0.00B 0.00
2015-09-30 $0.00B 0.00
2015-06-30 $0.00B 0.00
2014-12-31 $0.00B $-0.01B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.309B $0.031B
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.245B 12.24
Gilead Sciences (GILD) United States $85.342B 10.36
Celgene (CELG) United States $64.552B 10.94
Vertex Pharmaceuticals (VRTX) United States $45.118B 54.54
Biogen (BIIB) United States $44.896B 8.52
Illumina (ILMN) United States $44.438B 51.50
CSL (CSLLY) Australia $35.409B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.605B 15.32
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.541B 15.59
Incyte (INCY) United States $17.129B 69.46
Exact Sciences (EXAS) United States $14.845B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.750B 0.00
SINO PHARMACEUT (SBMFF) China $14.154B 0.00
Sarepta Therapeutics (SRPT) United States $11.364B 0.00
Genmab (GNMSF) Denmark $11.067B 56.26
Array BioPharma (ARRY) United States $10.346B 0.00
Seattle Genetics (SGEN) United States $10.192B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $8.908B 29.26
Galapagos (GLPG) Belgium $8.802B 0.00
Bio-Techne Corp (TECH) United States $7.964B 54.34
Alnylam Pharmaceuticals (ALNY) United States $7.909B 0.00
Guardant Health (GH) United States $7.720B 0.00
Bluebird Bio (BLUE) United States $7.368B 0.00
Amarin (AMRN) Ireland $7.189B 0.00
Exelixis (EXEL) United States $6.482B 16.52
BeiGene (BGNE) Cayman Islands $5.652B 0.00
Ascendis Pharma (ASND) Denmark $4.867B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.719B 0.00
Moderna (MRNA) United States $4.652B 0.00
Blueprint Medicines (BPMC) United States $4.628B 0.00
Horizon Pharma Public (HZNP) Ireland $4.408B 11.35
Repligen (RGEN) United States $4.177B 104.05
ACADIA Pharmaceuticals (ACAD) United States $3.787B 0.00
Spark Therapeutics (ONCE) United States $3.752B 0.00
Mirati Therapeutics (MRTX) United States $3.729B 0.00
China Biologic Products (CBPO) China $3.682B 23.39
Alkermes (ALKS) Ireland $3.668B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.401B 0.00
MorphoSys AG (MOR) Germany $3.316B 0.00
Arena Pharmaceuticals (ARNA) United States $3.062B 6.22
Amicus Therapeutics (FOLD) United States $2.899B 0.00
Immunomedics (IMMU) United States $2.772B 0.00
Medicines (MDCO) United States $2.740B 0.00
UniQure (QURE) Netherlands $2.631B 0.00
Reata Pharmaceuticals (RETA) United States $2.613B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.566B 0.00
Halozyme Therapeutics (HALO) United States $2.468B 0.00
MyoKardia (MYOK) United States $2.308B 0.00
Ligand Pharmaceuticals (LGND) United States $2.299B 19.04
Nabriva Therapeutics AG (NBRV) Ireland $2.251B 0.00
Emergent Biosolutions (EBS) United States $2.231B 19.38
NeoGenomics (NEO) United States $2.216B 145.06
Acceleron Pharma (XLRN) United States $2.160B 0.00
Zai Lab (ZLAB) China $2.106B 0.00
Genomic Health (GHDX) United States $2.078B 44.13
Akcea Therapeutics (AKCA) United States $2.072B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.046B 0.00
Denali Therapeutics (DNLI) United States $1.911B 0.00
Myriad Genetics (MYGN) United States $1.907B 18.97
REGENXBIO (RGNX) United States $1.720B 0.00
Insmed (INSM) United States $1.690B 0.00
Cambrex (CBM) United States $1.501B 18.98
Fate Therapeutics (FATE) United States $1.464B 0.00
AnaptysBio (ANAB) United States $1.431B 0.00
RA PHARMCTL INC (RARX) United States $1.421B 0.00
Innoviva (INVA) United States $1.405B 3.89
Sangamo Therapeutics (SGMO) United States $1.349B 0.00
Athenex (ATNX) United States $1.329B 0.00
Alector (ALEC) United States $1.311B 0.00
Coherus BioSciences (CHRS) United States $1.284B 0.00
Editas Medicine (EDIT) United States $1.198B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.185B 0.00
Epizyme (EPZM) United States $1.174B 0.00
Cara Therapeutics (CARA) United States $1.036B 0.00
Codexis (CDXS) United States $1.031B 0.00
Adverum Biotechnologies (ADVM) United States $1.013B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.013B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.979B 0.00
ANI Pharmaceuticals (ANIP) United States $0.976B 17.31
Twist Bioscience (TWST) United States $0.963B 0.00
Principia Biopharma (PRNB) United States $0.955B 0.00
Zymeworks (ZYME) Canada $0.940B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.928B 0.00
WAVE Life Sciences (WVE) Singapore $0.924B 0.00
Retrophin (RTRX) United States $0.873B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.873B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Vericel (VCEL) United States $0.854B 0.00
Arvinas (ARVN) United States $0.811B 0.00
Intellia Therapeutics (NTLA) United States $0.755B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.712B 33.60
Precision BioSciences (DTIL) United States $0.699B 0.00
Zealand Pharma (ZEAL) Denmark $0.683B 7.99
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Clovis Oncology (CLVS) United States $0.678B 0.00
Cytokineticsorporated (CYTK) United States $0.668B 0.00
Cellectis S.A (CLLS) France $0.647B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.640B 0.00
Intra-Cellular Therapies (ITCI) United States $0.640B 0.00
Heska (HSKA) United States $0.617B 63.16
DBV Technologies S.A (DBVT) France $0.604B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.589B 0.00
Anika Therapeutics (ANIK) United States $0.579B 19.79
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.575B 0.00
Stemline Therapeutics (STML) United States $0.568B 0.00
MiMedx (MDXG) United States $0.546B 0.00
Revance Therapeutics (RVNC) United States $0.542B 0.00
CytomX Therapeutics (CTMX) United States $0.537B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
Mesoblast (MESO) Australia $0.504B 0.00
PHARMA MAR SA (PHMMF) Spain $0.454B 0.00
UROGEN PHARMA (URGN) United States $0.447B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
Puma Biotechnology (PBYI) United States $0.417B 0.00
Prothena (PRTA) Ireland $0.386B 0.00
Biofrontera AG (BFRA) Germany $0.385B 0.00
PDL BioPharma (PDLI) United States $0.379B 9.06
AC Immune SA (ACIU) Switzerland $0.377B 24.26
Arcus Biosciences (RCUS) United States $0.376B 0.00
Gritstone Oncology (GRTS) United States $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Bellus Health (BLUSF) Canada $0.366B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.365B 0.00
Scholar Rock Holding (SRRK) United States $0.359B 0.00
Avid Bioservices (CDMO) United States $0.359B 0.00
Merus (MRUS) Netherlands $0.359B 0.00
Starpharma Holdings (SPHRY) Australia $0.356B 0.00
Prometic Life Sciences (PFSCD) Canada $0.348B 0.00
Albireo Pharma (ALBO) United States $0.346B 0.00
Agenus (AGEN) United States $0.344B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.343B 0.00
BioDelivery Sciences (BDSI) United States $0.340B 0.00
Senesco Technologies (ELOX) United States $0.337B 0.00
Acorda Therapeutics (ACOR) United States $0.331B 5.83
Kadmon Holdings (KDMN) United States $0.329B 0.00
Theratechnologies (THERF) Canada $0.328B 0.00
Syros Pharmaceuticals (SYRS) United States $0.324B 0.00
Sorrento Therapeutics (SRNE) United States $0.308B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.304B 0.00
Inovio Pharmaceuticals (INO) United States $0.294B 0.00
Cellular Biomedicine (CBMG) United States $0.270B 0.00
Kindred Biosciences (KIN) United States $0.269B 0.00
PHASEBIO PHARMA (PHAS) United States $0.263B 0.00
ChromaDex (CDXC) United States $0.262B 0.00
Sutro Biopharma (STRO) United States $0.261B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.260B 0.00
Dynavax Technologies (DVAX) United States $0.252B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.247B 0.00
Kamada (KMDA) Israel $0.238B 9.22
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
Athersys (ATHX) United States $0.232B 0.00
Geron (GERN) United States $0.226B 0.00
Palatin Technologies (PTN) United States $0.222B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.221B 0.00
Cel-Sci (CVM) United States $0.220B 0.00
Cerecor (CERC) United States $0.210B 0.00
MannKind (MNKD) United States $0.205B 0.00
Five Prime Therapeutics (FPRX) United States $0.204B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.198B 0.00
CorMedix Inc (CRMD) United States $0.198B 0.00
Abeona Therapeutics (ABEO) United States $0.196B 0.00
Synlogic (SYBX) United States $0.195B 0.00
Mersana Therapeutics (MRSN) United States $0.191B 0.00
Affimed (AFMD) Germany $0.191B 0.00
OSMOTICA PHARM (OSMT) United States $0.186B 0.00
Pfenex (PFNX) United States $0.186B 0.00
Spero Therapeutics (SPRO) United States $0.185B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
Arsanis (XFOR) United States $0.183B 0.00
Compugen (CGEN) Israel $0.182B 0.00
Enzo Biochem (ENZ) United States $0.178B 0.00
BioTime (BTX) United States $0.177B 11.80
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.163B 0.00
XOMA (XOMA) United States $0.158B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Strongbridge Biopharma (SBBP) United States $0.150B 8.63
OvaScience (MLND) United States $0.148B 0.00
Cue Biopharma (CUE) United States $0.148B 0.00
TOCAGEN INC (TOCA) United States $0.142B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
Adocia (ADOCY) France $0.140B 0.00
Celyad SA (CYAD) Belgium $0.140B 0.00
Northwest Biotherapeutics (NWBO) United States $0.135B 0.00
Dyadic (DYAI) United States $0.134B 0.00
NantKwest (NK) United States $0.127B 0.00
Seres Therapeutics (MCRB) United States $0.125B 0.00
Aptinyx (APTX) United States $0.123B 0.00
Alcobra (ARCT) United States $0.120B 0.00
Arbutus Biopharma (ABUS) Canada $0.119B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.119B 0.00
Menlo Therapeutics (MNLO) United States $0.118B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.116B 0.00
Verastem (VSTM) United States $0.114B 0.00
Novavax (NVAX) United States $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.103B 0.00
Catalyst Biosciences (CBIO) United States $0.103B 0.00
Checkpoint Therapeutics (CKPT) United States $0.103B 0.00
SESEN BIO, INC (SESN) United States $0.100B 0.00
Trevena (TRVN) United States $0.097B 0.00
Curis (CRIS) United States $0.094B 0.00
Fortress Biotech (FBIO) United States $0.093B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.085B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.084B 0.00
Pluristem Therapeutics (PSTI) Israel $0.084B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
VBI Vaccines (VBIV) United States $0.082B 0.00
AquaBounty Technologies (AQB) United States $0.081B 0.00
Unum Therapeutics (UMRX) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.075B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
Orgenesis (ORGS) United States $0.072B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 37.90
Organovo Holdings (ONVO) United States $0.067B 0.00
ARAVIVE, INC (ARAV) United States $0.063B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Antibe Therapeutics (ATBPF) Canada $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Invo BioScience (IVOB) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Ophthotech (ISEE) United States $0.051B 0.00
Proteostasis Therapeutics (PTI) United States $0.050B 0.00